@article{038fb4b752ef4a699977d7e159488e3b,
title = "Safety and Feasibility of a Novel Percutaneous Locoregional Injection Technique of Renal Cellular Therapy for Chronic Kidney Disease of Diabetes",
keywords = "cell therapy, chronic kidney disease, computed tomography, intervention, type 2 diabetic kidney disease",
author = "Hyeon Yu and Sonntag, \{Paul D.\} and Bream, \{Peter R.\} and Lazarowicz, \{Michael P.\} and Nowakowski, \{Francis S.\} and Woodhead, \{Gregory J.\} and Hennemeyer, \{Charles T.\} and Muller, \{Ryan D.\} and Rakesh Navuluri and Caoili, \{Elaine M.\} and Eifler, \{Aaron C.\} and Tominna, \{Brandon S.\} and Stavas, \{Joseph M.\}",
note = "Funding Information: The authors thank all ProKidney trial participants for advancing the science of cell therapy for CKD, Ms. Brenda McGrath for statistics preparation, Dr. Victor Silva Ritter for statistical analysis, and Dr. Maria D{\'i}az-Gonz{\'a}lez de Ferris for manuscript review. The trials have been censured by Institutional Review Board approval and participant informed consent. HY and JMS have made substantial contributions to the conception of the manuscript, drafting, and revisions of content, and agreed to be accountable for the accuracy and interpretation of the results data and approved the final version for publication. PDS, PRB, MPL, FSN, GJW, CTH, RDM, RN, EMC, ACE, and BST reviewed and agreed with manuscript content and approved the final version for publication. JMS is employed by ProKidney and an Executive Committee member. All the other authors have declared no conflict of interest.",
year = "2021",
month = sep,
doi = "10.1016/j.ekir.2021.06.014",
language = "English (US)",
volume = "6",
pages = "2486--2490",
journal = "Kidney International Reports",
issn = "2468-0249",
publisher = "Elsevier Inc.",
number = "9",
}